1. Cost-Effectiveness of Operating on Traumatic Spinal Injuries in Low-Middle Income Countries: A Preliminary Report From a Major East African Referral Center
- Author
-
Andreas Leidinger, Roger Härtl, Halinder S. Mangat, Noah L. Lessing, Ashley A. Leech, Hamisi K. Shabani, Scott L. Zuckerman, Nicephorus Rutabasibwa, and Albert Lazaro
- Subjects
medicine.medical_specialty ,biology ,Traumatic spinal cord injury ,Cost effectiveness ,business.industry ,Incidence (epidemiology) ,Middle income countries ,biology.organism_classification ,03 medical and health sciences ,0302 clinical medicine ,Tanzania ,Preliminary report ,Emergency medicine ,medicine ,Referral center ,Orthopedics and Sports Medicine ,Surgery ,Spine injury ,030212 general & internal medicine ,Neurology (clinical) ,business ,health care economics and organizations ,030217 neurology & neurosurgery - Abstract
Study Design: Retrospective cost-effectiveness analysis. Objectives: While the incidence of traumatic spine injury (TSI) is high in low-middle income countries (LMICs), surgery is rarely possible due to cost-prohibitive implants. The objective of this study was to conduct a preliminary cost-effectiveness analysis of operative treatment of TSI patients in a LMIC setting. Methods: At a tertiary hospital in Tanzania from September 2016 to May 2019, a retrospective analysis was conducted to estimate the cost-effectiveness of operative versus nonoperative treatment of TSI. Operative treatment included decompression/stabilization. Nonoperative treatment meant 3 months of bed rest. Direct costs included imaging, operating fees, surgical implants, and length of stay. Four patient scenarios were chosen to represent the heterogeneity of spine trauma: Quadriplegic, paraplegic, neurologic improvement, and neurologically intact. Disability-adjusted-life-years (DALYs) and incremental-cost-effectiveness ratios were calculated to determine the cost per unit benefit of operative versus nonoperative treatment. Cost/DALY averted was the primary outcome (i.e., the amount of money required to avoid losing 1 year of healthy life). Results: A total of 270 TSI patients were included (125 operative; 145 nonoperative). Operative treatment averaged $731/patient. Nonoperative care averaged $212/patient. Comparing operative versus nonoperative treatment, the incremental cost/DALY averted for each patient outcome was: quadriplegic ($112-$158/DALY averted), paraplegic ($47-$67/DALY averted), neurologic improvement ($50-$71/DALY averted), neurologically intact ($41-$58/DALY averted). Sensitivity analysis confirmed these findings without major differences. Conclusions: This preliminary cost-effectiveness analysis suggests that the upfront costs of spine trauma surgery may be offset by a reduction in disability. LMIC governments should consider conducting more spine trauma cost-effectiveness analyses and including spine trauma surgery in universal health care.
- Published
- 2020
- Full Text
- View/download PDF